Navigation Links
Hovione and Solvias Announce a Collaboration to Provide for Improved Drug Solubility

LISBON, Portugal, November 28, 2012 /PRNewswire/ --

Hovione and Solvias today announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's expertise and experience in overcoming drug delivery challenges and also the supply of GMP materials from phase I to commercial scale, with Solvias' excellence in solid state chemistry.

Hovione offers a series of innovative particle engineering technologies focused on amorphous solid dispersions, crystal design and reduction and control of particle size. The collaboration provides Hovione access to Solvias' co-crystallization expertise and capabilities, thus reinforcing and complementing the crystal design solutions to overcome poor bioavailability and other drug delivery challenges. Solvias continues its strategy of partnering to enhance access to its solid-state solutions.

"We are delighted to announce this collaboration with Solvias increasing the breadth of drug delivery solutions through our Particle Design offering. Solvias has a tremendous reputation for science, quality and expertise in crystal design for improved drug performance. This agreement reinforces our strategy of combining strengths with innovative companies to allow our customers a seamless and integrated approach to their drug delivery challenges." said Dr. Colin Minchom, Hovione's Vice President of Particle Design.

Dr. Martina Diekmann, Solvias' Global Head of Business Development Analytics commented "Solvias is delighted to work with Hovione.  In establishing this agreement with Hovione, we are able to generate added value for our customers and to help them solving their drug delivery requirements."

About Hovione. Hovione is a global company with over 50 years' experience in Active Pharmaceutical Ingredient and Drug Product Intermediate development and compliant manufacture. With four FDA inspected sites in the U.S., China, Ireland, and Portugal, the company focuses on the most demanding customers in the most regulated markets. Hovione offers integrated API, particle design, formulation development and GMP manufacturing. In the inhalation area, Hovione is the only independent company offering such a broad range of services.

About Solvias. Solvias is a privately held company located in Basel, Switzerland, with recognized high standards as a service provider to the pharmaceutical industry with full cGMP compliance (FDA, Swissmedic). With over 250 highly qualified employees, Solvias supports the research and development of new drug substances and drug products for pharmaceutical and life science companies worldwide.Solvias'profound know-how for analytical and chemical development, its experience and proven track record include:  Analytical Services for small molecules and biopharmaceuticals,;
Solid-State Services: Polymorphism, Salts, and Crystallization; Chemical Development and API Manufacturing up to phase II; Catalysis; Process Analytical Technology.

For more information about Hovione, please visit or contact Marketing & Communication,  Isabel Pina, +351-21-982-9362, e-mail:

For media requests, please contact: Tim Senn, Marketing Communication Manager at or +41-61-845-61-41

SOURCE Hovione
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Robbins Umeda LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Abiomed, Inc.
2. Echo Therapeutics Announces Proposed Public Offering
3. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
4. Alere Inc. Announces Offering of $450 Million of Senior Notes
5. Perrigo Announces FDA Final Approval Of Betamethasone Valerate Foam 0.12%
6. SHAREHOLDER ALERT: Morgan & Morgan announces an investigation of Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and whether senior management and the board of directors violated fiduciary duties owed to Vertex shareholders.
7. Regeneron Announces Presentation at the Deutsche Bank 2012 dbAccess BioFEST
8. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
9. Golden Meditech Announces 2012 / 2013 Interim Results
10. TriReme Announces a New Round of Financing Totalling US$18 Million
11. Baby Quasar announces the launch of its next-gen skin care tool, Clear Rayz, for the treatment of acne
Post Your Comments:
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/13/2017)...   OrthoAtlanta has been named the official orthopedic ... (AFHC) for the 2018 College Football Playoff (CFP) National Championship ... Stadium in Atlanta, Georgia . OrthoAtlanta is ... campaign, participating in many activities leading up to, and including ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work ... as “patient engagement.” The patient is doing more than filling out a survey; in ... “There is an increasing emphasis in health care and research on the importance of ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):